HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuwabara, S Articles by Hattori, T Search for Related Content PubMed PubMed Citation Articles by Kuwabara, S Articles by Hattori, T

Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases

¹ Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan
² Department of Neurosurgery, Graduate School of Medicine, Chiba University

Correspondence to:
Correspondence to:
Dr Satoshi Kuwabara
Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan; kuwabara-s{at}faculty.chiba-u.jp

Background: Little is known about long term prognosis and course after immune treatments in chronic inflammatory demyelinating polyneuropathy (CIDP).

Objective: To study long term outcomes and prognostic factors in patients with CIDP.

Methods: Clinical and electrophysiological findings, responses to immune modulating treatments, and outcomes five years after the start of treatment were reviewed in 38 CIDP patients.

Results: Patients were treated with corticosteroids (89%), immunoglobulin infusion (45%), or plasmapheresis (34%), and 58% received combined therapy. Five years after treatment was begun, 10 (26%) of the patients had complete remission (lasting >2 years with normal nerve conduction studies), and 23 (61%) had partial remission (able to walk) with (26%) or without (34%) immune treatments. The remaining five patients (13%) still had severe disability (unable to walk) or treatment dependent relapses. Patients with complete remission more often had subacute onset, symmetrical symptoms, good response to initial corticosteroid treatment, and nerve conduction abnormalities predominant in the distal nerve terminals. In contrast, insidious onset, asymmetrical symptoms, and electrophysiological evidence of demyelination in the intermediate nerve segments were associated with refractoriness to treatment or treatment dependent relapse.

Conclusions: The long term prognosis of CIDP patients was generally favourable, but 39% of patients still required immune treatments and 13% had severe disabilities. Mode of onset, distribution of symptoms, and electrophysiological characteristics may be prognostic factors for predicting a favourable outcome.

Abbreviations: CIDP, chronic inflammatory demyelinating polyneuropathy

Keywords: chronic inflammatory demyelinating polyneuropathy; prognosis; outcome; electrodiagnosis

This article has been cited by other articles:

				A Chio, D Cocito, E Bottacchi, C Buffa, M Leone, F Plano, R Mutani, A Calvo, and the PARCIDP Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1349 - 1353. [Abstract] [Full Text] [PDF]

				K-D Choi, J. S. Kim, H-J Kim, J-W Koo, J. H. Kim, C-Y Kim, C. W. Oh, and H. J. Kee Hyperventilation-induced nystagmus in peripheral vestibulopathy and cerebellopontine angle tumor Neurology, September 4, 2007; 69(10): 1050 - 1059. [Abstract] [Full Text] [PDF]